Woodline Partners LP

Position in SUPN — Supernus Pharmaceuticals, Inc.

CIK 1784547 San Francisco, CA

Position in SUPN

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$32,941,916

+$9,733,313 QoQ

Shares Held

708,276

+57.7% QoQ

Ownership

1.22%

of shares outstanding

% of Portfolio

0.10%

of 13F equity value

Holder Rank

#22

of 330 holders

Holding Since

Sep 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $232,519,537 across 16 Drug Manufacturers - Specialty & Generic names. SUPN ranks #3 (14.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TEVA	Teva Pharmaceutical Industries Ltd	1,189,584	$40,303,105
2	ELAN	Elanco Animal Health Inc	1,612,986	$39,695,585
3	SUPN	Supernus Pharmaceuticals, Inc. This page	708,276	$32,941,916
4	ALKS	Alkermes plc.	560,282	$29,358,776
5	PBH	Prestige Consumer Healthcare Inc.	359,721	$17,004,011
6	AMLX	Amylyx Pharmaceuticals, Inc.	846,387	$15,201,110
7	VTRS	Viatris Inc	803,143	$12,753,910
8	UTHR	UNITED THERAPEUTICS Corp	23,074	$12,502,185

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$32,941,916	708,276	+57.7%	Shares	Sole	2026-08-14
2026-03-31	$23,208,603	448,996	-64.5%	Shares	Sole	2026-05-15
2025-09-30	$60,397,527	1,263,811	+63.5%	Shares	Sole	2025-11-14
2025-06-30	$24,364,203	772,976	+82.4%	Shares	Sole	2025-08-14
2024-12-31	$15,325,620	423,828	+124.8%	Shares	Sole	2025-02-14
2024-09-30	$5,879,643	188,571	-85.4%	Shares	Sole	2024-11-14
2024-03-31	$44,045,936	1,291,291	+1119.6%	Shares	Sole	2024-05-15
2022-12-31	$3,776,668	105,878	-86.7%	Shares	Sole	2023-02-14
2022-09-30	$26,869,012	793,767	+39.6%	Shares	Sole	2022-11-14
2022-06-30	$16,443,304	568,579	+17.1%	Shares	Sole	2022-08-15
2022-03-31	$15,688,515	485,412	+800.3%	Shares	Sole	2022-05-16
2021-09-30	$1,437,913	53,915	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.